organization · Reporting owner

Hudson Executive Capital LP

Disclosed activity across 6 companies

Tapewire entity: 94081
SEC CIK: 0001652522

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CANTALOUPE, INC.CTLP · Entity 45433	10% owner	February 20, 2024	February 22, 2024
Cardtronics plcCATM · Entity 138760	Director · 10% owner	March 09, 2021	March 11, 2021
EAGLE PHARMACEUTICALS, INC.EGRX · Entity 85958	Director	October 24, 2019	October 28, 2019
Talkspace, Inc.TALK · Entity 22747	10% owner	November 23, 2021	November 24, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CANTALOUPE, INC.

Report date February 20, 2024 · Filed February 22, 2024

Jointly reported with HEC Management GP LLC, Braunstein Douglas L

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	9,270,694	Last balance in matching sequence After 2023-02-21 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2023-02-20 · Other · Disposed 2,884,584 · Balance 9,361,276 F1: This filing reports in-kind distribution of Issuer shares to the limited partners of special purpose vehicle HEC SPV IV LP. No consideration was paid in connection with these distributions. To further facilitate the return of capital to those limited partners, the Reporting Persons (defined below) sold 90,582 Issuer shares, including certain legended shares, and intent to distribute the net proceeds from those sales to the limited partners. The Reporting Persons have no current plans to sell any other shares of this Issuer but reserve their right to do so in their discretion. F2: In addition to Hudson Executive Capital LP ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Row 2 · 2023-02-21 · Sale · Disposed 90,582 · Balance 9,270,694 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions through a broker-dealer at prices ranging from $6.22 to $6.53, inclusive. The Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2: In addition to Hudson Executive Capital LP ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Common StockSEC Table I · non-derivative	Direct	20,212	Reported balance Holding disclosure · report date 2024-02-20 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 20,212 F6: These securities are directly owned by Douglas L. Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.

Filing footnotes · ownership attribution and instrument terms

F1: This filing reports in-kind distribution of Issuer shares to the limited partners of special purpose vehicle HEC SPV IV LP. No consideration was paid in connection with these distributions. To further facilitate the return of capital to those limited partners, the Reporting Persons (defined below) sold 90,582 Issuer shares, including certain legended shares, and intent to distribute the net proceeds from those sales to the limited partners. The Reporting Persons have no current plans to sell any other shares of this Issuer but reserve their right to do so in their discretion.

F2: In addition to Hudson Executive Capital LP ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities").

F3: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).

F4: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions through a broker-dealer at prices ranging from $6.22 to $6.53, inclusive. The Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F6: These securities are directly owned by Douglas L. Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.

Cardtronics plc

Report date March 09, 2021 · Filed March 11, 2021

Jointly reported with HEC Management GP LLC, Braunstein Douglas L

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	IndirectSee footnote	14,040	Reported balance After 2021-03-09 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-03-09 · Exercise / conversion · Acquired 5,952 · Balance 14,040 F1: Restricted Stock Units awarded on March 31, 2020. Restricted Stock Units converted into ordinary shares upon vesting in accordance with the Restricted Stock Unit Award Agreement. F2: These securities are directly owned by Mr. Braunstein in his capacity as a director of the Issuer. The other Reporting Persons included in this Form 4 do not have any pecuniary interest therein.
Restricted Stock UnitsSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2021-03-09 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-03-09 · Exercise / conversion · Disposed 5,952 · Balance 0 F1: Restricted Stock Units awarded on March 31, 2020. Restricted Stock Units converted into ordinary shares upon vesting in accordance with the Restricted Stock Unit Award Agreement. F2: These securities are directly owned by Mr. Braunstein in his capacity as a director of the Issuer. The other Reporting Persons included in this Form 4 do not have any pecuniary interest therein.
Restricted Stock UnitsSEC Table II · derivative / convertible security	IndirectSee footnote	3,491	Reported balance After 2021-03-10 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-03-10 · Grant · Acquired 3,491 · Balance 3,491 F7: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2022, and each Restricted Stock Unit will convert into one share of Cardtronics common stock at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company. F2: These securities are directly owned by Mr. Braunstein in his capacity as a director of the Issuer. The other Reporting Persons included in this Form 4 do not have any pecuniary interest therein.
Ordinary SharesSEC Table I · non-derivative	IndirectSee footnotes	8,644,880	Reported balance Holding disclosure · report date 2021-03-09 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 8,644,880 F3: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F6: Mr. Braunstein, a member of the board of directors of the Company, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock Units awarded on March 31, 2020. Restricted Stock Units converted into ordinary shares upon vesting in accordance with the Restricted Stock Unit Award Agreement.

F2: These securities are directly owned by Mr. Braunstein in his capacity as a director of the Issuer. The other Reporting Persons included in this Form 4 do not have any pecuniary interest therein.

F3: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities").

F4: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).

F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F6: Mr. Braunstein, a member of the board of directors of the Company, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934.

F7: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2022, and each Restricted Stock Unit will convert into one share of Cardtronics common stock at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company.

EAGLE PHARMACEUTICALS, INC.

Report date October 24, 2019 · Filed October 28, 2019

Jointly reported with HEC Management GP LLC, Braunstein Douglas L

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	732,777	Last balance in matching sequence After 2019-10-25 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2019-10-24 · Sale · Disposed 1,494 · Balance 748,214 F1: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $62.5600, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. F3: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Row 2 · 2019-10-25 · Sale · Disposed 15,437 · Balance 732,777 F1: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F6: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $64.1300, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4. F3: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c).

F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $62.5600, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

F5: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $64.1300, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.

Talkspace, Inc.

Report date November 23, 2021 · Filed November 24, 2021

Jointly reported with Braunstein Douglas L, HEC Management GP LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	11,340,600	Reported balance After 2021-11-23 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-11-23 · Purchase · Acquired 1,000,000 · Balance 11,340,600 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $1.98 to $2.19. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2: Hudson Executive Capital LP ("Hudson Executive"), as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the securities reported on this Form 4 (the "Subject Securities") for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934 (the "Exchange Act"). HEC Management GP LLC ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Exchange Act. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Exchange Act. F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Common StockSEC Table I · non-derivative	Direct	15,384	Reported balance Holding disclosure · report date 2021-11-23 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 15,384 F4: These securities are directly owned by Douglas L. Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.
Common StockSEC Table I · non-derivative	Direct	1,273,690	Reported balance Holding disclosure · report date 2021-11-23 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 1,273,690 F5: These securities are jointly held by Douglas L. Braunstein and Samara Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.
Common StockSEC Table I · non-derivative	IndirectBy Braunstein 2015 Trust	1,000,756	Reported balance Holding disclosure · report date 2021-11-23 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 1,000,756 F5: These securities are jointly held by Douglas L. Braunstein and Samara Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $1.98 to $2.19. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F2: Hudson Executive Capital LP ("Hudson Executive"), as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the securities reported on this Form 4 (the "Subject Securities") for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934 (the "Exchange Act"). HEC Management GP LLC ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Exchange Act. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Exchange Act.

F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F4: These securities are directly owned by Douglas L. Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.

F5: These securities are jointly held by Douglas L. Braunstein and Samara Braunstein. The other Reporting Persons included in this Form 4 do not have beneficial ownership of such securities.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Corindus Vascular Robotics, Inc.

Report date October 29, 2019 · Filed October 31, 2019

Jointly reported with HEC Management GP LLC

Section 16 reporting ended · disclosed 2019-10-31. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnote	Reported balance After 2019-10-29 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-10-29 · Disposition to issuer · Disposed 106,219 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2: These shares represent 85,482 shares of the Issuer's common stock and 20,737 restricted stock units ("RSUs"). F3: At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes. F4: At the Effective Time, each outstanding RSU converted into the right to receive a cash payment equal to the product of (i) $4.28 and (ii) the number of shares of the Issuer's common stock underlying the RSU as of the Effective Time, without interest and net of any applicable withholding taxes. F5: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP", together with Hudson Executive, the "Reporting Persons"), which has the same business address as Hudson Executive and may be deemed to have had a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F6: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Douglas L. Braunstein, a citizen of the United States of America, as Managing Partner of Hudson Executive and Managing Member of Management GP, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to have been the beneficial owner of the Subject Securities held by Mr. Braunstein. F7: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	Reported balance After 2019-10-29 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2019-10-29 · Disposition to issuer · Disposed 14,235,545 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F3: At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes. F5: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP", together with Hudson Executive, the "Reporting Persons"), which has the same business address as Hudson Executive and may be deemed to have had a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F6: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Douglas L. Braunstein, a citizen of the United States of America, as Managing Partner of Hudson Executive and Managing Member of Management GP, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to have been the beneficial owner of the Subject Securities held by Mr. Braunstein. F7: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Series A Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.25	IndirectSee Footnote	Reported balance After 2019-10-29 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-10-29 · Disposition to issuer · Disposed 540,000 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F10: At the Effective Time, each outstanding share of the Issuer's Series A Preferred Stock automatically converted into the right to receive $85.60, without interest and less any applicable withholding taxes. F8: The holders of shares of Series A Preferred Stock and Series A-1 Preferred Stock had the right, at any time and from time to time, at such holder's option, to convert all or any portion of such holder's shares of Series A Preferred Stock or Series A-1 Preferred Stock into fully paid and non-assessable shares of the Issuer's common stock. F9: The Series A Preferred Stock and Series A-1 Preferred Stock were perpetual and therefore had no expiration date. F5: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP", together with Hudson Executive, the "Reporting Persons"), which has the same business address as Hudson Executive and may be deemed to have had a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F6: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Douglas L. Braunstein, a citizen of the United States of America, as Managing Partner of Hudson Executive and Managing Member of Management GP, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to have been the beneficial owner of the Subject Securities held by Mr. Braunstein. F7: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.25	IndirectSee Footnote	Reported balance After 2019-10-29 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-10-29 · Disposition to issuer · Disposed 105,281.218 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F11: At the Effective Time, each outstanding share of the Issuer's Series A-1 Preferred Stock automatically converted into the right to receive $85.60, without interest and less any applicable withholding taxes. F8: The holders of shares of Series A Preferred Stock and Series A-1 Preferred Stock had the right, at any time and from time to time, at such holder's option, to convert all or any portion of such holder's shares of Series A Preferred Stock or Series A-1 Preferred Stock into fully paid and non-assessable shares of the Issuer's common stock. F9: The Series A Preferred Stock and Series A-1 Preferred Stock were perpetual and therefore had no expiration date. F5: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP", together with Hudson Executive, the "Reporting Persons"), which has the same business address as Hudson Executive and may be deemed to have had a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F6: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Douglas L. Braunstein, a citizen of the United States of America, as Managing Partner of Hudson Executive and Managing Member of Management GP, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to have been the beneficial owner of the Subject Securities held by Mr. Braunstein. F7: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.40 · Expires 2028-03-16	IndirectSee Footnote	Reported balance After 2019-10-29 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-10-29 · Disposition to issuer · Disposed 4,725,000 · Balance 0 F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F12: At the Effective Time, each outstanding warrant to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment (without interest) equal to (i) the product of (a) the excess, if any, of (1) $4.28 over (2) the per share exercise price of such warrant, and (b) the number of shares of the Issuer's common stock subject to such warrant as of the Effective Time, less (ii) any applicable withholding taxes. F5: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP", together with Hudson Executive, the "Reporting Persons"), which has the same business address as Hudson Executive and may be deemed to have had a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F6: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Douglas L. Braunstein, a citizen of the United States of America, as Managing Partner of Hudson Executive and Managing Member of Management GP, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to have been the beneficial owner of the Subject Securities held by Mr. Braunstein. F7: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").

F2: These shares represent 85,482 shares of the Issuer's common stock and 20,737 restricted stock units ("RSUs").

F3: At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes.

F4: At the Effective Time, each outstanding RSU converted into the right to receive a cash payment equal to the product of (i) $4.28 and (ii) the number of shares of the Issuer's common stock underlying the RSU as of the Effective Time, without interest and net of any applicable withholding taxes.

F5: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP", together with Hudson Executive, the "Reporting Persons"), which has the same business address as Hudson Executive and may be deemed to have had a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities").

F6: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Douglas L. Braunstein, a citizen of the United States of America, as Managing Partner of Hudson Executive and Managing Member of Management GP, may be deemed to have been the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to have been the beneficial owner of the Subject Securities held by Mr. Braunstein.

F7: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F8: The holders of shares of Series A Preferred Stock and Series A-1 Preferred Stock had the right, at any time and from time to time, at such holder's option, to convert all or any portion of such holder's shares of Series A Preferred Stock or Series A-1 Preferred Stock into fully paid and non-assessable shares of the Issuer's common stock.

F9: The Series A Preferred Stock and Series A-1 Preferred Stock were perpetual and therefore had no expiration date.

F10: At the Effective Time, each outstanding share of the Issuer's Series A Preferred Stock automatically converted into the right to receive $85.60, without interest and less any applicable withholding taxes.

F11: At the Effective Time, each outstanding share of the Issuer's Series A-1 Preferred Stock automatically converted into the right to receive $85.60, without interest and less any applicable withholding taxes.

F12: At the Effective Time, each outstanding warrant to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment (without interest) equal to (i) the product of (a) the excess, if any, of (1) $4.28 over (2) the per share exercise price of such warrant, and (b) the number of shares of the Issuer's common stock subject to such warrant as of the Effective Time, less (ii) any applicable withholding taxes.

TIVITY HEALTH, INC.

Report date May 07, 2020 · Filed May 11, 2020

Jointly reported with HEC Management GP LLC, Braunstein Douglas L

Section 16 reporting ended · disclosed 2020-05-11. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee footnotes	4,795,310	Reported balance After 2020-05-07 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2020-05-07 · Disposition to issuer · Disposed 3,960,000 · Balance 4,795,310 F1: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Short Call Option (obligation to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2020-08-21	IndirectSee footnotes	0	Reported balance After 2020-05-07 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-05-07 · Other · Acquired 43,776 · Balance 0 F4: Order executed by the Reporting Persons to close out the outstanding short call option (obligation to sell) for 4,377,600 shares of common stock of Tivity Health, Inc., as reported by the Reporting Persons on a Form 3 filed with the Securities and Exchange Commission on March 13, 2020. F1: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
Long Put Option (right to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2020-08-21	IndirectSee footnotes	0	Reported balance After 2020-05-07 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-05-07 · Disposition to issuer · Disposed 43,776 · Balance 0 F1: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities").

F2: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).

F3: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.

F4: Order executed by the Reporting Persons to close out the outstanding short call option (obligation to sell) for 4,377,600 shares of common stock of Tivity Health, Inc., as reported by the Reporting Persons on a Form 3 filed with the Securities and Exchange Commission on March 13, 2020.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 15, 2019 Filed Oct 15, 2019 18:24 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	3,909	$62.63	$244,835.92	Disclosure SEC source: 0001567619-19-019579 · doc1.xml · nonDerivative · entry 3 Hudson Executive Capital LP · CIK 0001652522 · Director HEC Management GP LLC · CIK 0001700567 · Director Braunstein Douglas L · CIK 0001495110 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 775,868 F1 · shares: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.5000 to $62.9300, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4. F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
October 14, 2019 Filed Oct 16, 2019 21:10 UTC	CANTALOUPE, INC. USAT · Entity 45433	PurchaseCommon Stock	80,000	$6.70	$536,024.00	Disclosure SEC source: 0001567619-19-019663 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 10,220,172 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in transactions at prices ranging from $6.5800 to $7.0000, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares acquired at each separate price within the range set forth in footnote (1) to this Form 4. F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
October 11, 2019 Filed Oct 15, 2019 18:24 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	16,300	$60.39	$984,418.94	Disclosure SEC source: 0001567619-19-019579 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · Director HEC Management GP LLC · CIK 0001700567 · Director Braunstein Douglas L · CIK 0001495110 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 779,777 F1 · shares: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.0000 to $61.1200, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4. F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
October 10, 2019 Filed Oct 15, 2019 18:24 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	7,829	$60.16	$471,002.03	Disclosure SEC source: 0001567619-19-019579 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director HEC Management GP LLC · CIK 0001700567 · Director Braunstein Douglas L · CIK 0001495110 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 796,077 F1 · shares: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.0000 to $60.4900, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
October 08, 2019 Filed Oct 9, 2019 16:13 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	1,558	$60.03	$93,519.73	Disclosure SEC source: 0001567619-19-019404 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · Director HEC Management GP LLC · CIK 0001700567 · Director Braunstein Douglas L · CIK 0001495110 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 803,906 F1 · shares: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.0000 to $60.0515, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4. F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
October 07, 2019 Filed Oct 9, 2019 16:13 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	4,901	$60.11	$294,599.60	Disclosure SEC source: 0001567619-19-019404 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director HEC Management GP LLC · CIK 0001700567 · Director Braunstein Douglas L · CIK 0001495110 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 805,464 F1 · shares: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.0000 to $60.2650, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
September 26, 2019 Filed Sep 26, 2019 21:52 UTC	CANTALOUPE, INC. USAT · Entity 45433	PurchaseCommon Stock	605,000	$4.87	$2,943,325.00	Disclosure SEC source: 0001567619-19-018805 · doc1.xml · nonDerivative · entry 3 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 10,140,172 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $4.500 to $5.150, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4. F1 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
September 25, 2019 Filed Sep 26, 2019 21:52 UTC	CANTALOUPE, INC. USAT · Entity 45433	PurchaseCommon Stock	1,176,000	$4.43	$5,213,913.60	Disclosure SEC source: 0001567619-19-018805 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 9,535,172 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $4.135 to $5.100, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. F1 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
September 24, 2019 Filed Sep 26, 2019 21:52 UTC	CANTALOUPE, INC. USAT · Entity 45433	PurchaseCommon Stock	20,000	$4.40	$88,000.00	Disclosure SEC source: 0001567619-19-018805 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,359,172 F1 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F3 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
September 23, 2019 Filed Sep 23, 2019 21:34 UTC	CANTALOUPE, INC. USAT · Entity 45433	PurchaseCommon Stock	143,200	$4.46	$638,672.00	Disclosure SEC source: 0001567619-19-018668 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,339,172 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $4.37 to $4.50, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
September 19, 2019 Filed Sep 23, 2019 21:34 UTC	CANTALOUPE, INC. USAT · Entity 45433	PurchaseCall Option (right to buy) · Derivative	12,500	$0.50 Strike: $10.00	$6,250.00	Disclosure SEC source: 0001567619-19-018668 · doc1.xml · derivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 12,500 Underlying: Common Stock · 1,250,000 shares Expires 2020-01-17 F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
September 17, 2019 Filed Sep 19, 2019 16:13 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	100	$60.00	$6,000.00	Disclosure SEC source: 0001567619-19-018534 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director HEC Management GP LLC · CIK 0001700567 · Director Braunstein Douglas L · CIK 0001495110 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 810,365 F1 · shares: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
September 12, 2019 Filed Sep 13, 2019 16:43 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	200	$60.07	$12,014.00	Disclosure SEC source: 0001567619-19-018305 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · Director HEC Management GP LLC · CIK 0001700567 · Director Braunstein Douglas L · CIK 0001495110 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 810,465 F1 · shares: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
September 11, 2019 Filed Sep 13, 2019 16:43 UTC	EAGLE PHARMACEUTICALS, INC. EGRX · Entity 85958	SaleCommon Stock	1,112	$60.06	$66,784.94	Disclosure SEC source: 0001567619-19-018305 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director HEC Management GP LLC · CIK 0001700567 · Director Braunstein Douglas L · CIK 0001495110 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 810,665 F1 · shares: The sale of shares set forth herein is made pursuant to a sales plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.23, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
August 05, 2019 Filed Aug 5, 2019 21:18 UTC	CANTALOUPE, INC. USAT · Entity 45433	SaleShort Put Option (obligation to buy) · Derivative	5,300	$1.40 Strike: $7.00	$7,420.00	Disclosure SEC source: 0001567619-19-015815 · doc1.xml · derivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires 2020-03-20 F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
August 05, 2019 Filed Mar 6, 2020 21:36 UTC Amendment	CANTALOUPE, INC. USAT · Entity 45433	SaleShort Put Option (obligation to buy) · Derivative	5,300	$1.40 Strike: $7.00	$7,420.00	Disclosure SEC source: 0001567619-20-005830 · doc1.xml · derivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,300 Underlying: Common Stock · 530,000 shares Expires 2020-03-20 F1 · derivative.underlying_shares: This amended report is being filed to correct the number of shares of common stock of USA Technologies Inc. underlying the short put options, from 5,300 to 530,000, sold by the Reporting Persons (defined below) on August 5, 2019. F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 amendment is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 amendment (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
August 01, 2019 Filed Aug 5, 2019 21:18 UTC	CANTALOUPE, INC. USAT · Entity 45433	PurchaseCommon Stock	1,000,252	$6.93	$6,931,746.36	Disclosure SEC source: 0001567619-19-015815 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,195,972 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $6.60 to $6.93, inclusive. The Reporting Persons (defined below) undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. F2 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
March 13, 2019 Filed Mar 15, 2019 20:53 UTC	Cardtronics plc CATM · Entity 138760	GrantRestricted Stock Units · Derivative	4,278	Not disclosed	Not disclosed	Disclosure SEC source: 0001567619-19-007016 · doc1.xml · derivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 4,278 Underlying: Ordinary Shares · 4,278 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Cardtronics ordinary shares and are awarded under the Issuer's current Stock Incentive Plan and subject to the terms of a Restricted Stock Unit Agreement. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Cardtronics ordinary shares and are awarded under the Issuer's current Stock Incentive Plan and subject to the terms of a Restricted Stock Unit Agreement. F2 · derivative.exercise_date: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Issuer for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2020. In the event Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Issuer. F2 · derivative.expiration_date: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Issuer for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2020. In the event Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Issuer. F2 · ownership.direct: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Issuer for the next 12 months. The forfeiture restrictions on the units shall lapse on March 9, 2020. In the event Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Issuer. F3 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited liability company ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F6 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
March 12, 2019 Filed Mar 14, 2019 17:46 UTC	Corindus Vascular Robotics, Inc. CVRS · Entity 154132	PurchaseCommon Stock	2,899,391	$1.38	$3,999,999.82	Disclosure SEC source: 0001567619-19-006904 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,235,545 F1 · ownership.nature: In addition to Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP", together with Hudson Executive, the "Reporting Persons"), which has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F2 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). Douglas L. Braunstein, a citizen of the United States of America, as Managing Partner of Hudson Executive and Managing Member of Management GP, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F3 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
March 08, 2019 Filed Mar 12, 2019 15:45 UTC	Cardtronics plc CATM · Entity 138760	Exercise / conversionRestricted Stock Units · Derivative	3,810	Not disclosed	Not disclosed	Disclosure SEC source: 0001567619-19-006652 · doc1.xml · derivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Ordinary Shares · 3,810 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F1 · shares: Restricted stock units converted into ordinary shares upon vesting. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F3 · derivative.exercise_date: Restricted Stock Units were awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units lapsed on March 8, 2019, and each restricted stock unit converted on that date into one share of Cardtronics ordinary shares. F3 · derivative.expiration_date: Restricted Stock Units were awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units lapsed on March 8, 2019, and each restricted stock unit converted on that date into one share of Cardtronics ordinary shares. F3 · ownership.direct: Restricted Stock Units were awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units lapsed on March 8, 2019, and each restricted stock unit converted on that date into one share of Cardtronics ordinary shares. F4 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F5 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F6 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F7 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
March 08, 2019 Filed Mar 12, 2019 15:45 UTC	Cardtronics plc CATM · Entity 138760	Exercise / conversionOrdinary Shares	3,810	Not disclosed	Not disclosed	Disclosure SEC source: 0001567619-19-006652 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,130,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units converted into ordinary shares upon vesting. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F3 · ownership.direct: Restricted Stock Units were awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units lapsed on March 8, 2019, and each restricted stock unit converted on that date into one share of Cardtronics ordinary shares. F4 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F5 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F6 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F7 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
August 13, 2018 Filed Aug 15, 2018 17:00 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	54,898	$29.89	$1,640,901.22	Disclosure SEC source: 0001567619-18-001200 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,126,933 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $29.68 to $30.00. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F5 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
August 10, 2018 Filed Aug 10, 2018 17:28 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	12,350	$30.22	$373,217.00	Disclosure SEC source: 0001567619-18-000430 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · Director · 10% owner Braunstein Douglas L · CIK 0001495110 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,072,035 F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $30.00 to $30.42. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F5 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
August 08, 2018 Filed Aug 10, 2018 17:28 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	12,850	$29.73	$382,030.50	Disclosure SEC source: 0001567619-18-000430 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · Director · 10% owner Braunstein Douglas L · CIK 0001495110 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,059,685 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $29.50 to $29.97. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 and footnote 6 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F5 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
June 20, 2018 Filed Jun 22, 2018 17:41 UTC	Cardtronics plc CATM · Entity 138760	GrantRestricted Stock Units · Derivative	3,810	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-18-029644 · doc1.xml · derivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · Director · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 3,810 Underlying: Ordinary Shares · 3,810 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Cardtronics ordinary shares. F2 · derivative.exercise_date: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units shall lapse on March 8, 2019, and each restricted stock unit will convert into one share of Cardtronics ordinary shares at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company. F2 · derivative.expiration_date: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units shall lapse on March 8, 2019, and each restricted stock unit will convert into one share of Cardtronics ordinary shares at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company. F2 · ownership.direct: Restricted Stock Units awarded to Mr. Braunstein in connection with his anticipated service as a director for the Company in 2018. The forfeiture restrictions on the units shall lapse on March 8, 2019, and each restricted stock unit will convert into one share of Cardtronics ordinary shares at that time. In the event that Mr. Braunstein's service as a director ends prior to such date, the units will be forfeited back to the Company. F3 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities reported on this Form 4 (the "Subject Securities"). F4 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) and Hudson Executive and Management GP may be deemed to be the beneficial owner of the Subject Securities held by Mr. Braunstein. F5 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. F6 · ownership.nature: Mr. Braunstein, a member of the board of directors of the Issuer of the Subject Securities, was appointed to that board as a representative of the Reporting Persons. As a result, each of those persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document
May 03, 2018 Filed May 4, 2018 17:08 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	24,000	$25.34	$608,160.00	Disclosure SEC source: 0001140361-18-021786 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,046,835 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $24.95 to $25.65. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
May 02, 2018 Filed May 4, 2018 17:08 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	119,000	$25.32	$3,013,080.00	Disclosure SEC source: 0001140361-18-021786 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 8,022,835 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $25.01 to $25.70. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 and 5 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 27, 2018 Filed Apr 30, 2018 18:48 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	122,150	$25.92	$3,166,128.00	Disclosure SEC source: 0001140361-18-020589 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,903,835 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $25.65 to $26.03. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 26, 2018 Filed Apr 30, 2018 18:48 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	85,000	$25.87	$2,198,950.00	Disclosure SEC source: 0001140361-18-020589 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,781,685 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $25.73 to $26.05. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 and 5 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 20, 2018 Filed Apr 24, 2018 17:18 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	350,500	$25.39	$8,899,195.00	Disclosure SEC source: 0001140361-18-019416 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,696,685 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $25.06 to $25.58. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
April 11, 2018 Filed Apr 13, 2018 19:39 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	958,355	$23.55	$22,569,260.25	Disclosure SEC source: 0001140361-18-018582 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 7,346,185 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $22.85 to $23.55. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other Reporting Persons undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
March 29, 2018 Filed Apr 2, 2018 17:13 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	63,100	$22.47	$1,417,857.00	Disclosure SEC source: 0001140361-18-016473 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,387,830 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $22.35 to $22.64. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other reporting person undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
February 21, 2018 Filed Feb 23, 2018 15:44 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	5,810	$24.00	$139,440.00	Disclosure SEC source: 0001140361-18-009829 · doc1.xml · nonDerivative · entry 3 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,324,730 F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $24.00 to $24.01. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
February 21, 2018 Filed Feb 23, 2018 15:44 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	278,402	$23.39	$6,511,822.78	Disclosure SEC source: 0001140361-18-009829 · doc1.xml · nonDerivative · entry 2 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,318,920 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $23.00 to $23.99. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document
February 21, 2018 Filed Feb 23, 2018 15:44 UTC	Cardtronics plc CATM · Entity 138760	PurchaseOrdinary Shares	37,788	$22.73	$858,921.24	Disclosure SEC source: 0001140361-18-009829 · doc1.xml · nonDerivative · entry 1 Hudson Executive Capital LP · CIK 0001652522 · 10% owner HEC Management GP LLC · CIK 0001700567 · 10% owner Braunstein Douglas L · CIK 0001495110 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 6,040,518 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions through a broker-dealer at prices ranging from $22.00 to $22.99. Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive") and the other reporting person undertake to provide Cardtronics plc, any security holder of Cardtronics plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1, footnote 5 and footnote 6 to this Form 4. F2 · ownership.nature: In addition to Hudson Executive, this Form 4 is being filed jointly by HEC Management GP LLC, a Delaware limited liability company ("Management GP"), and Douglas L. Braunstein, a citizen of the United States of America (together with Hudson Executive and Management GP, the "Reporting Persons"), each of whom has the same business address as Hudson Executive and may be deemed to have a pecuniary interest in the securities beneficially owned by Hudson Executive (the "Subject Securities"). F3 · ownership.nature: Hudson Executive, as the investment adviser to certain affiliated investment funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934. Management GP, as the general partner of Hudson Executive, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). F4 · ownership.nature: Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.